朗廷-SS(01270.HK):信託集團酒店一季度經營毛利下跌110%
格隆匯5月12日丨朗廷-SS(01270.HK)公佈,截至2020年3月31日止3個月,由於爆發新型冠狀病毒(Covid-19)繼續嚴重影響信託集團下的酒店業務營運,信託集團酒店的合計經營毛利較去年同期下跌大約110%。截至2020年3月31日止三個月期間的合計浮動租金收入較去年同期大幅下跌。
公司預期在新型冠狀病毒肆虐期間限制了旅遊及社交聚會下,酒店業務營運將會繼續受到嚴重影響。信託集團將繼續每年獲得固定租金收入2.25億港元。然而,此收入將被融資及營運成本所抵銷。由於業績惡化,公司預期將不會派發截至2020年6月30日止六個月的中期分派予股份合訂單位持有人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.